Risk Factors Found for Neurogenic Bladder After Rectal Cancer Surgery
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 6, 2024 -- Lower abdominal visceral fat area (VFA), older age, and prolonged surgery are independent risk factors for developing postoperative neurogenic bladder (PONB) after rectal cancer surgery, according to a study published online Sept. 27 in BMC Gastroenterology.
Tomohiro Matsui, M.D., from Kyoto Prefectural University of Medicine in Japan, and colleagues analyzed risk factors for developing PONB after rectal cancer surgery. The analysis included 138 patients who underwent rectal resection for lower rectal cancer (2017 to 2021).
The researchers reported that 19 patients developed PONB, with 16 being severe cases. PONB was more common in patients with a height of <158 cm, age 70 years and older, surgery lasting eight or more hours, intraoperative bleeding volume ≥150 mL, lateral lymph node dissection, and a narrower pelvis. Additionally, PONB was more prevalent in cases with low VFA at the umbilical level. Gender, body mass index, and medical history were not significantly correlated with PONB. Independent risk factors for PONB included older age, prolonged surgery, and low VFA, while low VFA, older age, prolonged surgery, and a deep pelvis were independent risk factors for severe PONB.
"This result is contrary to the instinctive impression that many surgeons have that cases with low visceral fat are less prone to nerve damage caused by surgical manipulation because the surgical difficulty is not high," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-07 06:00
Read more
- FDA Approves Hympavzi (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- Most ERs Not Fully Equipped to Treat Pediatric Patients
- Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
- Patients Living Outside Metropolitan Statistical Areas Travel Farther for Health Care Visits
- First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions